CSIMarket Company Name, Ticker, Industry, else..


Edwards Lifesciences Corporation  (NYSE: EW)
Other Ticker:  
 

Edwards Lifesciences Corporation

EW's Fundamental analysis



Edwards Lifesciences's sales fell by -8.58 % in III. Quarter 2024 from the same quarter a year ago. Ranking at No. 1205

Medical Equipment & Supplies industry recorded growth of revenues by 1.68 %

Edwards Lifesciences's net income grew by 699.95 % in III. Quarter 2024 year on year, above company average,

• More on EW's Growth


Edwards Lifesciences
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

Edwards Lifesciences PEG ratio is at 0.05 Company is currently trading with Price to Cash flow multiple of 19.45 in trailing twelve-month period.
Company
10.65
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 7.52.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.31.


• More on EW's Valuation
 
 Total Debt (Millions $) 598
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 296,485
 Net Income/Employee (TTM) $ 209,854
 Receivable Turnover (TTM) 7.61
 Tangible Book Value (Per Share $) 11.79

Edwards Lifesciences
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

Edwards Lifesciences PEG ratio is at 0.05 Company is currently trading with Price to Cash flow multiple of 19.45 in trailing twelve-month period.
Company
10.65
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 7.52.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.31.

Edwards Lifesciences Price to Book Ratio is at 4.59 higher than Industry Avg. of -568.46, and higher than S&P 500 Avg. of 0.01

• More on EW's Valuation

•  Market Capitalization (Millions $) 44,146
•  Shares Outstanding (Millions) 598
•  Employees 19,800
•  Revenues (TTM) (Millions $) 5,870
•  Net Income (TTM) (Millions $) 4,155
•  Cash Flow (TTM) (Millions $) 2,270
•  Capital Exp. (TTM) (Millions $) -330
•  Total Debt (Millions $) 598
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 296,485
•  Net Income/Employee(TTM) $ 209,854
•  Receivable Turnover Ratio (TTM) 7.61
•  Tangible Book Value (Per Share $) 11.79

•  Market Capitalization (Millions $) 44,146
•  Shares Outstanding (Millions) 598
•  Employees 19,800
•  Revenues (TTM) (Millions $) 5,870
•  Net Income (TTM) (Millions $) 4,155
•  Cash Flow (TTM) (Millions $) 2,270
•  Capital Exp. (TTM) (Millions $) -330


    EW's Profitability Comparisons
Edwards Lifesciences faced margin deterioration, primarily through cost pressure. Operating Margin fell in III. Quarter 2024 to 25.9 % from 26.64 % in II. Quarter.

Edwards Lifesciences net profit margin of 226.78 % is currently ranking no. 1 in Medical Equipment & Supplies industry, ranking no. 5 in Healthcare sector and number 38 in S&P 500.


Profitability by Segment
Total 226.78 %



  Ratio
•   Capital Ratio (MRQ) 3.46
•  Total Debt to Equity (MRQ) 0.06
•  Tangible Leverage Ratio (MRQ) 0.49
•  Asset Turnover Ratio (TTM) 0.61
•  Inventory Turnover Ratio (TTM) 1.14



Edwards Lifesciences faced margin deterioration, primarily through cost pressure. Operating Margin fell in III. Quarter 2024 to 25.9 % from 26.64 % in II. Quarter.

Edwards Lifesciences net profit margin of 226.78 % is currently ranking no. 1 in Medical Equipment & Supplies industry, ranking no. 5 in Healthcare sector and number 38 in S&P 500.

• More on EW's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com